Cargando…

Dyslipidemic drugs in metabolic syndrome

INTRODUCTION: Metabolic syndrome predisposes to diabetes and atherosclerotic vascular disease. Statins reduce cardiovascular events, so all metabolic syndrome patients should be evaluated for dyslipidemia. Many patients fail to achieve lipid goals with statin monotherapy. Co-administration of ezetim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Siddiqi, Sheelu S., Misbahuddin, Ahmad, Farida, Rahman, Syed Z., Khan, Asad U.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712379/ https://www.ncbi.nlm.nih.gov/pubmed/23869305 http://dx.doi.org/10.4103/2230-8210.111644

Ejemplares similares

Depression contributing to dyslipidemic cardiovascular risk in the metabolic syndrome
por: Lemche, A. V., et al.
Publicado: (2016)

Type-2 diabetes mellitus and auditory brainstem response
por: Siddiqi, Sheelu S., et al.
Publicado: (2013)

The effect of dyslipidemic drugs on mortality: A meta-analysis
por: Jain, Shuchi, et al.
Publicado: (2009)

Cardiac Mitochondria Dysfunction in Dyslipidemic Mice
por: Braczko, Alicja, et al.
Publicado: (2022)

Effects of bezafibrate on lipid and glucose metabolism in dyslipidemic patients with diabetes: the J-BENEFIT study
por: Teramoto, Tamio, et al.
Publicado: (2012)

Serum lysophospholipid levels are altered in dyslipidemic hamsters
por: Suárez-García, Susana, et al.
Publicado: (2017)

Potential benefits of L. acidophilus in dyslipidemic rats
por: Reamtong, Onrapak, et al.
Publicado: (2021)

Pharmacokinetic interaction of garlic and atorvastatin in dyslipidemic rats
por: Reddy, G. Dilip, et al.
Publicado: (2012)

LDL Particle Size and Reactive Oxygen Metabolites in Dyslipidemic Patients
por: Kotani, Kazuhiko, et al.
Publicado: (2012)

Addressing dyslipidemic risk beyond LDL-cholesterol
por: Tall, Alan R., et al.
Publicado: (2022)

Dose-dependent anti-hyperglycemic & anti-dyslipidemic potential of aqueous leaves extract of Typha elephantina in-vivo and in-vitro
por: Ahmad, Bashir, et al.
Publicado: (2023)

Effect of Flaxseed Powder on Cardiovascular Risk Factor in Dyslipidemic and Hypertensive Patients
por: Haghighatsiar, Naemeh, et al.
Publicado: (2019)

Grape juice attenuates left ventricular hypertrophy in dyslipidemic mice
por: Martins, Ângela Maria, et al.
Publicado: (2020)

Association between Remnant-Like Particle Cholesterol and Gamma-Glutamyltransferase in Dyslipidemic Patients
por: Kotani, Kazuhiko, et al.
Publicado: (2013)

OSBPL10, a novel candidate gene for high triglyceride trait in dyslipidemic Finnish subjects, regulates cellular lipid metabolism
por: Perttilä, Julia, et al.
Publicado: (2009)

The Link between Magnesium Supplements and Statin Medication in Dyslipidemic Patients
por: Nartea, Roxana, et al.
Publicado: (2023)

A study of bone turnover markers in gestational diabetes mellitus
por: Siddiqi, Sheelu Shafiq, et al.
Publicado: (2017)

Effects of Astrocaryum aculeatum Meyer (Tucumã) on Diet-Induced Dyslipidemic Rats
por: Craveiro Holanda Malveira Maia, Geórgia, et al.
Publicado: (2014)

Effects of citral on oxidative stress and hepatic key enzymes of glucose metabolism in streptozotocin/high-fat-diet induced diabetic dyslipidemic rats
por: Mishra, Chetna, et al.
Publicado: (2019)

Role of maraviroc in a dyslipidemic murine model of atherosclerosis RTV-induced
por: Cipriani, S, et al.
Publicado: (2012)

The use of probiotics for improving lipid profiles in dyslipidemic individuals: an overview protocol
por: Fortes, Patricia M., et al.
Publicado: (2018)

Proof-of-concept study for liver-directed miQURE technology in a dyslipidemic mouse model
por: Zancanella, Vanessa, et al.
Publicado: (2023)

Aerobic Exercise Training Selectively Changes Oxysterol Levels and Metabolism Reducing Cholesterol Accumulation in the Aorta of Dyslipidemic Mice
por: Ferreira, Guilherme Silva, et al.
Publicado: (2017)

Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction
por: Tenenbaum, Alexander, et al.
Publicado: (2012)

Interleukin-1-Beta and Dyslipidemic Syndrome as Major Risk Factors for Thrombotic Complications in Type 2 Diabetes Mellitus
por: Bădulescu, Oana, et al.
Publicado: (2013)

Thyroid volumes and serum VEGF levels in dyslipidemic patients: effects of statin treatment
por: AYDIN, Kadriye, et al.
Publicado: (2019)

Sphingolipid serum profiling in vitamin D deficient and dyslipidemic obese dimorphic adults
por: Al-Daghri, Nasser M., et al.
Publicado: (2019)

Outcome of dyslipidemic covid 19 patients in intensive care unit submitted to hemodialysis
por: Martinez, T.L.R., et al.
Publicado: (2021)

Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients
por: Barakat, Lolwa, et al.
Publicado: (2013)

Inflammation but Not Endothelial Dysfunction Is Associated with the Severity of Coronary Artery Disease in Dyslipidemic Subjects
por: Rueda-Clausen, Christian F., et al.
Publicado: (2009)

Comparison of efficacy, safety, and cost-effectiveness of various statins in dyslipidemic diabetic patients
por: Bener, Abdulbari, et al.
Publicado: (2014)

Quercetin Beneficial Role in the Homeostatic Variation of Certain Trace Elements in Dyslipidemic Mice
por: Muselin, Florin, et al.
Publicado: (2022)

Correlation of compliance to statin therapy with lipid profile and serum HMGCoA reductase levels in dyslipidemic patients
por: Grover, Abhinav, et al.
Publicado: (2017)

Improvement of antioxidant status after Brazil nut intake in hypertensive and dyslipidemic subjects
por: Huguenin, Grazielle V. B., et al.
Publicado: (2015)

Association of classical markers and establishment of the dyslipidemic sub-phenotype of sickle cell anemia
por: Aleluia, Milena Magalhães, et al.
Publicado: (2017)

Risk factors and quality of life of dyslipidemic patients in Lebanon: A cross-sectional study
por: Farhat, Akram, et al.
Publicado: (2016)

Simvastatin down-regulates the production of Interleukin-8 by neutrophil leukocytes from dyslipidemic patients
por: Marino, Franca, et al.
Publicado: (2014)

Effect of Camellia sinensis teas on left ventricular hypertrophy and insulin resistance in dyslipidemic mice
por: Ferreira, M.C.L., et al.
Publicado: (2020)

Regulation of lipid metabolism-related gene expression in whole blood cells of normo- and dyslipidemic men after fish oil supplementation
por: Schmidt, Simone, et al.
Publicado: (2012)

Comparison of Food and Nutrient Intakes between Japanese Dyslipidemic Patients with and without Low-Density Lipoprotein Cholesterol Lowering Drug Therapy: A Cross-Sectional Study
por: Kameyama, Noriko, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tefa971ana6jkcncg1ddkm5m2j